홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GKOS
#1098
Glaukos Corporation
120.8
5
USD
+1.59%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.59%
월간 변동
+21.41%
6달 변화
+40.38%
년간 변동율
+29.93%
이전 종가
118.9
6
Open
120.5
0
Bid
Ask
Low
120.3
8
High
121.4
6
양
168
마켓
주식
헬스케어
GKOS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
45.79 M
47.05 M
47.88 M
49.47 M
56.57 M
58.08 M
—
Valuation ratios
Enterprise value
3.56 B
2.3 B
2.29 B
4.03 B
8.31 B
6.47 B
22.38 B
Price to earnings ratio
-27.87
-41.53
-21
-27.73
-54.13
-34.42
-196.3
Price to sales ratio
14.89
7.02
7.36
11.86
20.63
12.73
48.76
Price to cash flow ratio
-145.68
83.5
-62.93
-64.64
-129
-436.63
-1 051.09
Price to book ratio
5.02
3.51
3.93
8.08
10.31
9.84
15.1
EBITDA 비율에 대한 기업 가치
-35.57
-619.85
-39.05
-39.14
-95.85
-132.95
-445
Profitability ratios
Return on assets %
-0.12
-0.05
-0.1
-0.14
-0.15
-0.21
-0.2
Return on equity %
-0.18
-0.08
-0.19
-0.29
-0.19
-0.29
-0.27
Return on invested capital %
-80.32
-23.95
-48.3
-65.48
-65.48
-108.46
-101.49
Gross margin %
59.23
77.34
75.61
75.99
75.48
55.72
232.88
Operating margin %
-54.92
-11.18
-29.1
-40.89
-31.91
-39.33
-147.65
EBITDA margin %
-41.86
-1.09
-17.94
-30.2
-22.61
-9.59
-38.83
Net margin %
-53.5
-16.87
-35.07
-42.79
-38.17
-36.99
-138.39
Liquidity ratios
Quick ratio
9.13
7.31
5.61
4.78
5.22
4.06
18.84
Current ratio
9.45
7.67
6.13
5.34
5.99
4.69
21.88
Inventory turnover
3.14
3.43
2.27
1.89
1.89
1.84
1.8
Asset turnover
0.25
0.29
0.28
0.32
0.4
0.54
0.52
Solvency ratios
Debt to assets ratio
0.21
0.3
0.31
0.33
—
—
—
Debt to equity ratio
0.32
0.53
0.59
0.68
—
—
—
Long term debt to total assets ratio
0.19
0.27
0.28
0.3
—
—
—
Long term debt to total equity ratio
0.28
0.48
0.53
0.61
—
—
—
Per share metrics
Operating cash flow per share
-0.52
0.53
-0.7
-1.19
-1.16
-0.26
-0.26
EBIT per share
-2.78
-0.71
-1.73
-2.66
-2.32
-1.52
-1.52
EBITDA per share
-2.12
-0.07
-1.07
-1.96
-1.64
-0.85
-0.85
Total debt per share
4.75
6.69
6.55
6.49
—
—
—
Cash per share
9.3
9.12
2.52
1.93
3.22
1.59
7.08
Net current asset value per share
10.55
10.47
9.36
8.17
8.53
8.31
31.7
Tangible book value per share
5.48
4.05
3.29
2.33
8.29
7.83
30.72
Working capital per share
9.43
9.11
7.83
6.64
7.1
6.53
25.81
Book value per share
15
12.65
11.17
9.53
14.54
11.47
51.74
뉴스
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?
스티펠, Glaukos에 대한 ’매수’ 등급 재확인
Stifel reiterates Glaukos stock rating on product momentum
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
글라우코스, iDose 및 Epioxa 성장세에 Needham 목표가 상향
Needham raises Glaukos stock price target on iDose, Epioxa growth
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
글라우코스, iDose·Epioxa 출시 시점 맞아 실적 발표 예정